AstraZeneca, the pharmaceutical giant, has declared a worldwide retraction of their COVID-19 vaccine due to legal hiccups relating to its side-effects.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Worried about the Delta variant of COVID-19? Two doses of Covishield and Pfizer COVID-19 vaccines may be 90% effective against the deadly variant.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
Blood clotting has been reported in some individuals after receiving COVID-19 vaccines. This condition is also known as Thrombosis.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
Got jabbed with the COVID-19 vaccines? A new study by Lancet has revealed that the antibodies start declining after 10 weeks. Read on to know more.
In two separate studies, researchers have found cases of a rare neurological disorder in recipients of AstraZeneca's COVID-19 vaccine. Read on to know more.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.
The woman had received an initial dose of AstraZeneca vaccine on May 25. She died on Thursday. Reports said she had low blood platelet count and was on double hormone therapy before the vaccination.
Rare blood clotting which is also known as thrombosis is a reported side effect that is being reported by the recipients of the AstraZeneca COVID-19 vaccine. Here's all you need to know about the disorder.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
So far, Australia has confirmed three cases of thrombosis with thrombocytopenia linked to the AstraZeneca vaccine. But the country's medical regulator maintains that the benefits of AstraZeneca vaccine outweigh the risks.
In India, AstraZeneca vaccine is locally developed under the brand name 'Covishield' by the Serum Institute of India. It is one of the two vaccines currently being administered to the eligible population.
However, the WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that the cases of blood clots among individuals who have received the AstraZeneca vaccine are very rare.
Some seven people died after experiencing a rare blood clotting syndrome after receiving Oxford-AstraZeneca's COVID-19 vaccination in the United Kingdom. Read on to know more about the syndrome and how to stay safe.
The risk of blood clots associated with AstraZeneca COVID-19 vaccine is "very small," says Britain's Medicines and Healthcare products Regulatory Agency (MHRA). Meanwhile, Australian media have reported a case of blood clotting disorder days after receiving the AstraZeneca vaccine.
Many countries have stopped providing AstraZeneca Covid-19 vaccine to adults under 55 years of age given that the potential risks associated with vaccine-induced prothrombotic immune thrombocytopenia.
US-based National Institute of Allergy and Infectious Diseases (NIAID) accuses AstraZneeca of providing outdated information on the efficacy data related to its COVID-19 vaccine.
AstraZeneca vaccine or Covishield is one of the two Covid-19 vaccines approved for emergency use in India. Several countries have suspended its use after reports of blood clots among vaccinated people.
The use of the AstraZeneca vaccine has been suspended in Denmark, Austria, Italy, Bulgaria, Romania, Estonia, Lithuania, Luxembourg, Latvia and non-European Union (EU) countries Norway and Iceland over fear of serious adverse reactions.
AstraZeneca, the pharmaceutical giant, has declared a worldwide retraction of their COVID-19 vaccine due to legal hiccups relating to its side-effects.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Worried about the Delta variant of COVID-19? Two doses of Covishield and Pfizer COVID-19 vaccines may be 90% effective against the deadly variant.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
Blood clotting has been reported in some individuals after receiving COVID-19 vaccines. This condition is also known as Thrombosis.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
Got jabbed with the COVID-19 vaccines? A new study by Lancet has revealed that the antibodies start declining after 10 weeks. Read on to know more.
In two separate studies, researchers have found cases of a rare neurological disorder in recipients of AstraZeneca's COVID-19 vaccine. Read on to know more.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.
The woman had received an initial dose of AstraZeneca vaccine on May 25. She died on Thursday. Reports said she had low blood platelet count and was on double hormone therapy before the vaccination.
Rare blood clotting which is also known as thrombosis is a reported side effect that is being reported by the recipients of the AstraZeneca COVID-19 vaccine. Here's all you need to know about the disorder.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
So far, Australia has confirmed three cases of thrombosis with thrombocytopenia linked to the AstraZeneca vaccine. But the country's medical regulator maintains that the benefits of AstraZeneca vaccine outweigh the risks.
In India, AstraZeneca vaccine is locally developed under the brand name 'Covishield' by the Serum Institute of India. It is one of the two vaccines currently being administered to the eligible population.
However, the WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that the cases of blood clots among individuals who have received the AstraZeneca vaccine are very rare.
Some seven people died after experiencing a rare blood clotting syndrome after receiving Oxford-AstraZeneca's COVID-19 vaccination in the United Kingdom. Read on to know more about the syndrome and how to stay safe.
The risk of blood clots associated with AstraZeneca COVID-19 vaccine is "very small," says Britain's Medicines and Healthcare products Regulatory Agency (MHRA). Meanwhile, Australian media have reported a case of blood clotting disorder days after receiving the AstraZeneca vaccine.
Many countries have stopped providing AstraZeneca Covid-19 vaccine to adults under 55 years of age given that the potential risks associated with vaccine-induced prothrombotic immune thrombocytopenia.
US-based National Institute of Allergy and Infectious Diseases (NIAID) accuses AstraZneeca of providing outdated information on the efficacy data related to its COVID-19 vaccine.
AstraZeneca vaccine or Covishield is one of the two Covid-19 vaccines approved for emergency use in India. Several countries have suspended its use after reports of blood clots among vaccinated people.
The use of the AstraZeneca vaccine has been suspended in Denmark, Austria, Italy, Bulgaria, Romania, Estonia, Lithuania, Luxembourg, Latvia and non-European Union (EU) countries Norway and Iceland over fear of serious adverse reactions.
